Sector Category: Life Sciences

NSV News Portfolio News
Ventyx Biosciences
June 6, 2020

Ventyx Biosciences

Developing selective inhibitors of TYK2 for autoimmune diseases.

Read More
Morrow
November 1, 2018

Morrow

Focused on the commercialization of spectacles with digital lens technology.

Read More
ChromaCure
October 3, 2018

ChromaCure

Focused on the development of a first-in-class oncology therapeutic.

Read More
NorthSea Therapeutics
June 13, 2018

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Read More
Seahorse Bioscience
October 17, 2017

Seahorse Bioscience

Acquired by Agilent Technologies. Developer of tools for measuring cell metabolism.

Read More
K2M
October 17, 2017

K2M

Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.

Read More
FlowCardia
October 17, 2017

FlowCardia

Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.

Read More
Dezima
October 17, 2017

Dezima

Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.

Read More
Conor Medsystems
October 17, 2017

Conor Medsystems

Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.

Read More
Ception
October 17, 2017

Ception

Acquired by Cephalon. Focused on the development of a biologic therapy for the treatment of asthma.

Read More
Biovex
October 17, 2017

Biovex

Acquired by Amgen. Focused on the development of an oncolytic vaccine for melanoma and head and neck cancer.

Read More
Akarna Therapeutics
October 17, 2017

Akarna Therapeutics

Acquired by Allergan. Focused on the development of a small molecule therapy for the treatment of NASH.

Read More